Has Ryan Hostutler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,195 in general payments to Ryan Hostutler, MD across 290 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Hostutler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Hostutler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Hostutler, MD

Pain Medicine · Easley, SCNPI 1336559830

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Abbott at 31.9% of the total. Reporting peaked in 2020 at $2,254 and has fallen 67.6% since, to $731 in 2025.

$8,195in general payments, 2019–2025

Across 290 payments — averaging $28.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$3K
Medtronic$2K
Vertos Medical, Inc.$806
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$356
Relievant Medsystems, Inc.$356
Saluda Medical Americas, Inc.$332
plus $2K from 17 others

What the payments were for

Food & beverage$8,195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	112	$2,614
Medtronic	51	$1,755
Vertos Medical, Inc.	29	$806
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	20	$356
Relievant Medsystems, Inc.	14	$356
Saluda Medical Americas, Inc.	5	$332
Averitas Pharma Inc.	13	$297
Boston Scientific	7	$287
Nevro Corp.	4	$223
Curonix LLC	4	$199
Spinal Simplicity, LLC	2	$178
Forte Bio-pharma LLC	2	$170
Si-bone, Inc.	2	$166
Biodelivery Sciences International, Inc.	7	$102
Novo Nordisk	5	$87
Globus Medical	1	$83
Redhill Biopharma Inc.	3	$46
MML US, Inc.	3	$44
Arbor Pharmaceuticals, Inc.	2	$35
Scilex Pharmaceuticals Inc.	1	$19
Indivior Inc.	1	$14
Biohaven Pharmaceutical Holding Company Ltd.	1	$14
Almatica Pharma LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,195 in reported general payments places this provider in the 70th percentile of 92 pain medicine providers in South Carolina.

See all pain medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024

$101,229

Medicare patients

237

Services billed

798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	41	$635
Gabapentin	16	$282
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	33	$230
Baclofen	22	$162
Cephalexin	18	$106
Oxycodone Hcl	26	$76
Meloxicam	12	$33

Paid to pharmacies, not to this prescriber.

Other pain medicine in Easley

Joseph O QuinnEasley$6K
Stephen WatsonEasley$1K
Phillip SmithGreenville$303K
Richard KlineConway$104K
Channing WilloughbyMurrells Inlet$82K
Michael WarrickSumter$50K
Daniel AtkinsonGreenville$36K
Michael WardenFlorence$20K
Andrew MendelsonCharleston$19K
Sankeerth ChallagundlaColumbia$15K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →